A detailed history of West Paces Advisors Inc. transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, West Paces Advisors Inc. holds 117 shares of LH stock, worth $23,746. This represents 0.01% of its overall portfolio holdings.

Number of Shares
117
Previous 145 19.31%
Holding current value
$23,746
Previous $33 Million 22.21%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$209.01 - $232.56 $5,852 - $6,511
-28 Reduced 19.31%
117 $25.6 Million
Q4 2023

Jan 30, 2024

BUY
$197.69 - $227.29 $988 - $1,136
5 Added 3.57%
145 $33 Million
Q4 2022

Dec 18, 2023

BUY
$203.72 - $248.97 $28,520 - $34,855
140 New
140 $33 Million
Q3 2022

Dec 18, 2023

SELL
$204.81 - $262.19 $19,456 - $24,908
-95 Reduced 38.46%
152 $31.1 Million
Q1 2022

Dec 18, 2023

BUY
$259.82 - $298.18 $27,800 - $31,905
107 Added 76.43%
247 $65.1 Million
Q4 2021

Dec 19, 2023

BUY
$271.6 - $314.21 $28,518 - $32,992
105 Added 73.94%
247 $77.6 Million
Q2 2021

Dec 19, 2023

BUY
$251.87 - $278.14 $23,927 - $26,423
95 Added 202.13%
142 $39.2 Million
Q1 2021

Dec 19, 2023

BUY
$204.88 - $255.03 $7,170 - $8,926
35 Added 291.67%
47 $12 Million
Q2 2020

Dec 19, 2023

SELL
$113.31 - $182.44 $14,503 - $23,352
-128 Reduced 91.43%
12 $1.99 Million
Q3 2018

Dec 20, 2023

SELL
$167.67 - $188.27 $21,461 - $24,098
-128 Reduced 91.43%
12 $2.08 Million
Q4 2017

Dec 21, 2023

SELL
$147.99 - $163.95 $2,071 - $2,295
-14 Reduced 53.85%
12 $1.91 Million
Q1 2017

Dec 21, 2023

SELL
N/A
-3 Reduced 10.34%
26 $3.73 Million
Q4 2016

Dec 21, 2023

SELL
N/A
-111
29 $3.72 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.2B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track West Paces Advisors Inc. Portfolio

Follow West Paces Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.